News

First, MyCareLink Heart works only with Medtronic’s BlueSync-enabled pacemakers, billed as “the world’s first and only portfolio of pacemakers” capable of communicating directly with ...
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global ...
The AI algorithm is shaped by Medtronic's vast library of heart monitoring data. "We really are focusing on data and how we're turning data into the right therapy for patients," Brewer said.
In an attempt to offer a comprehensive diagnostic tools portfolio for heart patients, Medtronic, Inc. (MDT) recently launched the SEEQ Mobile Cardiac Telemetry (:MCT) System in the U.S. market, ...
Medtronic’s tiny, insertable cardiac monitor has gotten an upgrade: The FDA cleared a new version of the Reveal Linq, which now includes algorithms that ramp up the implant’s accuracy in ...
Medtronic launched the wireless, adhesive heart monitor that it acquired when it bought startup Corventis in June reportedly for more than $150 million. The monitor can be worn up to 30 days to ...
The concept of remote monitoring of patients with pacemakers is not new — Medtronic already has more than 1 million users on its CareLink Network who transmit data from their cardiac devices.
Medtronic officially launched the app, dubbed MyCareLink Heart, to enable patients to access data from their pacemakers on their smartphones. The app isn’t meant to replace patient interactions ...
After receiving the necessary regulatory approval, Medtronic is launching its latest product on the global market. The medical devices company announced on Wednesday that it has received clearance ...
As many as 750,000 heart devices made by Medtronic PLC contain a serious cybersecurity vulnerability that could let an attacker with sophisticated insider knowledge to harm a patient by altering ...
WASHINGTON (MarketWatch) -- A U.S. Food and Drug Administration panel Thursday rejected a first-of-a-kind device by Medtronic Inc. MDT, +0.44% designed to monitor the condition of heart-failure ...